The journal aims to:

• Publish high-impact research in cancer biology, molecular oncology, translational therapeutics, and precision medicine.
• Promote innovation in diagnostics, imaging, genomics, artificial intelligence, immunotherapy, and novel therapeutic delivery systems in oncology.
• Bridge laboratory research and clinical application by disseminating translational studies, early-phase trials, biomarker validation, and real-world evidence.
• Encourage interdisciplinary collaboration among oncologists, biomedical engineers, data scientists, pharmaceutical innovators, and health-systems researchers.
• Support global oncology efforts, including in low- and middle-income countries, by publishing research on access, implementation, equity and outcomes in cancer treatment.

The journal covers all major domains of oncology including but not limited to solid tumours, hematologic malignancies, cancer prevention, early detection, imaging/radiomics, immuno-oncology, targeted therapy, surgical oncology, radiation oncology, survivorship and palliative care.